Jean-Sébastien Frénel

28PUBLICATIONS
147CO-AUTHORS
Predictive and prognostic markersDeep learningModels of care and place of birthMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Feb 18, 2026
Development and Assessment of a Pipeline for Extracting Structured Data From Free-Text Medical Reports Using a Large Language Model.

Enzo Joseph, Paul Vallee, Tanguy Perennec

|Jan 15, 2026
ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial.

Guillaume Beinse, Valerie Taly, Alexandra Leary

|Jan 08, 2026
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.

Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev

|Oct 01, 2025
Real-world analysis of HER2-ultralow in HR+/HER2- metastatic breast cancer: prevalence and first-line chemotherapy outcomes.

Laurent Mathiot, Olivier Kerdraon, Florent Le Borgne

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

Pageof 5

Frequent Collaborators

4 joint publications

Thomas Bachelot

3 joint publications

William Jacot

3 joint publications

Etienne Brain

2 joint publications

Suzette Delaloge